Protege, the platform for AI training data, today announced a strategic partnership with HistoWiz, a leader in digital pathology services, to digitize pathology slides and make them accessible for artificial intelligence (AI) model development in healthcare.
Evident is broadening its digital pathology applications with the addition of Z-stack capabilities* on the SLIDEVIEW™ VS-M1 whole slide scanner. By adding intuitive sample-based workflows, including preset protocols for prevalent cytology samples, the company continues to innovate its digital pathology portfolio for clinical research applications.
Lumea, a leader in digital pathology solutions, is proud to announce that its Viewer+™ software has received FDA 510(k) clearance, solidifying its role as a cutting-edge, centralized diagnostic hub for pathologists. This clearance ensures that Viewer+, our Digital Diagnostic Suite™, meets the highest standards of safety and effectiveness, allowing it to be used for primary diagnosis in clinical settings.
Aiosyn, a pioneering pathology software company specializing in AI-powered solutions for cancer and kidney disease, and Pramana, industry leader in automated digital pathology solutions, announced a collaboration to deliver inline detection of kidney structures in histology whole-slide images (WSIs). Leveraging the industry's first and only digital pathology scanners with integrated Edge AI computing technology from Pramana, Aiosyn’s NephroPath platform* streamlines renal biopsy and resection assessments.
Aiforia Technologies, a pioneer in AI-powered image analysis in pathology, today announced a partnership with Quorum Technologies. This collaboration seeks to accelerate the adoption of Aiforia’s AI-assisted image analysis solutions across Canada. By combining their collective expertise, the companies aim to enhance scientific discoveries and patient care through improved accuracy and increased workflow efficiency in digital pathology image analysis.
In a recent study, researchers at Mayo Clinic shed new light on the complex landscape of Alzheimer’s disease, revealing a spectrum of disease subtypes with distinct clinical, pathological, and cellular features. By examining over 1,300 brain samples and using innovative analytical techniques, researchers have uncovered significant associations between the distribution of abnormal tau protein in the brain, clinical symptoms, and patterns of glial cell activation.
The future of computational pathology extends far beyond automated pattern recognition, according to Geert J. S. Litjens, PhD, who delivered a compelling keynote address
Pathologists and laboratorians are increasingly overwhelmed by the sheer volume, complexity, and rapid evolution of diagnostic data. From lengthy pathology reports to intricate genomic profiles, extracting actionable insights is a significant and growing challenge. This report provides a practical solution accessible today: harnessing the power of large language models (LLMs) through effective prompt engineering.
The future of computational pathology extends far beyond automated pattern recognition, according to Geert J. S. Litjens, PhD, who delivered a compelling keynote address
In the fast-evolving biotech landscape, speed and transparency are critical to staying ahead. As industry leaders like Moderna, BioNTech, and Pfizer demonstrate the transformative power of agility in research and development, researchers must address inefficiencies to maintain their competitive edge. In this context, HistoWiz’s Digital Block Management Solution emerges as a game-changer, providing unparalleled transparency, 24/7 access, and rapid turnaround times for histology orders.
